Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

May 26, 2026

Study Completion Date

May 26, 2026

Conditions
Gestational DiabetesGlucose Metabolism DisordersMetabolic Disease
Interventions
DEVICE

Wearable Care Group

"Continous glucose monitoring sensor: Study participants wear the sensor on the back of either right or left upper arm for up to 14 days. Glucose levels will be recorded from the interstitial fluid every 15 minutes using intermittent/ flash glucose scanning.~Exercise tracker: A FitBit watch will be given to the participants for use to track physical activity levels."

Trial Locations (1)

229899

RECRUITING

KK Women's and Children's Hospital, Singapore

All Listed Sponsors
collaborator

Duke-NUS Graduate Medical School

OTHER

collaborator

Institute for Human Development and Potential (IHDP), Singapore

OTHER

lead

KK Women's and Children's Hospital

OTHER_GOV

NCT05081037 - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) | Biotech Hunter | Biotech Hunter